We provide you with 20 years of free, institutional-grade data for AXSM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AXSM. Explore the full financial landscape of AXSM stock.
Total insider purchase within 3 month on this page: $200,340
Total insider selling within 3 month on this page: -$28,510,288
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Jacobson Mark L. | Sale | -10,000 | $115.96 | $1,159,600 | 2025-09-22 |
| Jacobson Mark L. | Derivatives Exercise | 10,000 | 2025-09-22 | ||
| Jacobson Mark L. | Derivatives Exercise | 40,000 | 2025-09-17 | ||
| Jacobson Mark L. | Sale | -45,783 | $116.19 | $5,319,527 | 2025-09-17 |
| TABUTEAU HERRIOT | Sale | -62,880 | $118.96 | $7,480,205 | 2025-09-16 |
| TABUTEAU HERRIOT | Derivatives Exercise | 62,880 | 2025-09-16 | ||
| Coleman Mark | Open Market Purchase | 1,575 | $127.2 | 2025-09-09 | |
| Saad Mark E | Sale | -9,127 | $125.07 | $1,141,514 | 2025-09-05 |
| Saad Mark E | Derivatives Exercise | 9,127 | 2025-09-05 | ||
| JEFFS ROGER | Sale | -13,464 | $123.68 | $1,665,228 | 2025-09-02 |
| JEFFS ROGER | Sale | -60,000 | $122.3 | $7,338,000 | 2025-08-29 |
| JEFFS ROGER | Sale | -36,694 | $120.08 | $4,406,216 | 2025-08-26 |
| Murdock Hunter R. | Sale | -13,514 | $102.47 | $1,384,780 | 2025-06-23 |
| Murdock Hunter R. | Derivatives Exercise | 13,514 | 2025-06-23 | ||
| Murdock Hunter R. | Sale | -22,500 | $102.42 | $2,304,450 | 2025-06-18 |
| Murdock Hunter R. | Derivatives Exercise | 22,500 | 2025-06-18 | ||
| Jacobson Mark L. | Sale | -25,000 | $110.44 | $2,761,000 | 2025-06-10 |
| Jacobson Mark L. | Derivatives Exercise | 25,000 | 2025-06-10 | ||
| Coleman Mark | Sale | -7,500 | $105.47 | $791,025 | 2025-05-29 |
| Jacobson Mark L. | Sale | -40,673 | $104.66 | $4,256,836 | 2025-05-28 |
| Jacobson Mark L. | Derivatives Exercise | 40,673 | 2025-05-28 | ||
| Coleman Mark | Sale | -3,000 | $107.49 | $322,473 | 2025-05-20 |
| Pizzie Nick | Sale | -15,000 | $129.86 | $1,947,900 | 2025-02-14 |
| Pizzie Nick | Derivatives Exercise | 15,000 | 2025-02-14 | ||
| Coleman Mark | Derivatives Exercise | 9,127 | 2025-01-06 | ||
| Coleman Mark | Derivatives Exercise | 33,410 | 2024-11-20 | ||
| Saad Mark E | Sale | -11,016 | $91.31 | $1,005,871 | 2024-09-11 |
| Saad Mark E | Derivatives Exercise | 11,016 | 2024-09-11 | ||
| Jacobson Mark L. | Sale | -47,739 | $84.26 | $4,022,488 | 2024-08-09 |
| Jacobson Mark L. | Derivatives Exercise | 47,739 | 2024-08-09 | ||
| Jacobson Mark L. | Sale | -7,910 | $74.31 | $587,813 | 2024-05-29 |
| Jacobson Mark L. | Derivatives Exercise | 13,693 | 2024-05-29 | ||
| Coleman Mark | Sale | -10,497 | $75.21 | $789,474 | 2024-05-29 |
| Jacobson Mark L. | Sale | -24,662 | $77.24 | $1,904,942 | 2024-04-01 |
| Jacobson Mark L. | Derivatives Exercise | 24,662 | 2024-04-01 | ||
| JEFFS ROGER | Sale | -32,323 | $69.7 | $2,252,978 | 2024-03-15 |
| JEFFS ROGER | Derivatives Exercise | 32,323 | 2024-03-15 | ||
| Coleman Mark | Sale | -18,572 | $75.18 | $1,396,189 | 2023-09-15 |
| Coleman Mark | Sale | -11,016 | $75.19 | $828,241 | 2023-09-15 |
| Coleman Mark | Derivatives Exercise | 11,016 | 2023-09-15 | ||
| Coleman Mark | Derivatives Exercise | 17,501 | 2023-01-04 |
The information provided in this report about AXSM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Axsome Therapeutics, Inc(NASDAQ:AXSM) 
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in t...
Website: http://www.axsome.com
Founded: 2012
Full Time Employees: 53
Sector: Healthcare
Industry: Biotechnology